Overview RSPR-007 Mannitol Challenge Trial Status: Completed Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary This is a double-blind, randomised, placebo-controlled, cross-over, Phase 2 trial evaluating two doses (a low and a high) of CRD007 for the treatment of asthmatic trial subjects with a positive asthma test (mannitol challenge) prior to enrolment. Phase: Phase 2 Details Lead Sponsor: RSPR Pharma ABTreatments: MannitolPemirolast